Skip to main content
×
Blacklisted Listed News Logo
Menu - Navigation
Menu - Navigation

Cited Sources

2nd Smartest Guy in the World
2nd Amendment Shirts
10th Amendment Center
Aaron Mate
Activist Post
AIER
Aletho News
Ammo.com
AmmoLand
Alliance for Natural Health, The
Alt-Market
American Free Press
Antiwar
Armstrong Economics
Art of Liberty
AUTOMATIC EARTH, The
Ben Bartee
Benny Wills
Big League Politics
Black Vault, The
BOMBTHROWER
Brandon Turbeville
Breaking Defense
Breitbart
Brownstone Institute
Burning Platform, The
Business Insider
Business Week
Caitlin Johnstone
Campus Reform
CAPITALIST EXPLOITS
Charles Hugh Smith
Children's Health Defense
CHRISTOPHE BARRAUD
Chris Wick
CIAgate
Citizen Free Press
Citizens for Legit Gov.
CNN Money
Collective Evolution
Common Dreams
Conscious Resistance Network
Corbett Report
Counter Signal, The
Cryptogon
Cryptome
Daily Bell, The
Daily Reckoning, The
Daily Veracity
DANERIC'S ELLIOTT WAVES
Dark Journalist
David Haggith
Defense Industry Daily
Defense Link
Defense One
Dennis Broe
DOLLAR COLLAPSE
DR. HOUSING BUBBLE
Dr. Robert Malone
Drs. Wolfson
Drudge Report
Economic Collapse, The
ECONOMIC POPULIST, The
Electronic Frontier Foundation
Ellen Brown
Emerald Robinson
Expose, The
F. William Engdahl
FAIR
Farm Wars
Faux Capitalist
FINANCIAL REVOLUTIONIST
Forbes
Foreign Policy Journal
FOREXLIVE
Foundation For Economic Freedom
Free Thought Project, The
From Behind Enemy Lines
From The Trenches
FUNDIST
Future of Freedom Foundation
Futurism
GAINS PAINS & CAPITAL
GEFIRA
Geopolitical Monitor
Glenn Greenwald
Global Research
Global Security
GM RESEARCH
GOLD CORE
Grayzone, The
Great Game India
Guadalajara Geopolitics
Helen Caldicott
Homeland Sec. Newswire
Human Events
I bank Coin
IEEE
IMPLODE-EXPLODE
Information Clearing House
Information Liberation
Infowars
Insider Paper
Intel News
Intercept, The
Jane's
Jay's Analysis
Jeff Rense
John Adams
John Pilger
John W. Whitehead
Jonathan Cook
Jon Rappoport
Jordan Schachtel
Just The News
Kevin Barret
Kitco
Last American Vagabond, The
Lew Rockwell
Le·gal In·sur·rec·tion
Libertarian Institute, The
Libertas Bella
LIBERTY BLITZKRIEG
LIBERTY Forcast
Liberty Unyielding
Market Oracle
Market Watch
Maryanne Demasi
Matt Taibbi
Medical Express
Media Monarchy
Mercola
Michael Snyder
Michael Tracey
Middle East Monitor
Mike "Mish" Shedlock
Military Info Tech
Mind Unleashed, The
Mint Press
MISES INSTITUTE
Mises Wire
MISH TALK
Money News
Moon of Alabama
Motherboard
My Budget 360
Naked Capitalism
Natural News
New American, The
New Eastern Outlook
News Deck
New World Next Week
Nicholas Creed
OF TWO MINDS
Off-Guardian
Oil Price
OPEN THE BOOKS
Organic Prepper, The
PANDEMIC: WAR ROOM
PETER SCHIFF
Phantom Report
Pierre Kory
Political Vigilante
Public Intelligence
Rair
Reclaim The Net
Revolver
Richard Dolan
Right Turn News
Rokfin
RTT News
Rutherford Institute
SAFEHAVEN
SAKER, The
Shadow Stats
SGT Report
Shadowproof
Slay News
Slog, The
SLOPE OF HOPE
Solari
South Front
Sovereign Man
Spacewar
spiked
SPOTGAMMA
Steve Kirsch
Steve Quayle
Strange Sounds
Strike The Root
Summit News
Survival Podcast, The
Tech Dirt
Technocracy News
Techno Fog
Terry Wahls, M.D.
TF METALS REPORT
THEMIS TRADING
Tom Renz
True Activist
unlimited hangout
UNREDACTED
Unreported Truths
Unz Review, The
VALUE WALK
Vigilant Citizen
Voltaire
Waking Times
Wall Street Journal
Wallstreet on Parade
Wayne Madsen
What Really Happened
Whitney Webb
winter oak
Wolf Street
Zero Hedge

FDA ‘Turned a Blind Eye' to 'Submission of Fraudulent Data' on COVID Vaccine, Says Former Criminal Investigator

Published: December 13, 2022 | Print Friendly and PDF
  Gab
Share

On Nov. 2, 2021, The BMJ broke the story of Brook Jackson, the regional director who blew the whistle on data integrity issues in Pfizer’s pivotal COVID-19 vaccine trial. Weeks later, documents were leaked supporting Jackson’s complaint about “falsified data.”

Among the leaked documents was an email, authored by a former federal agent in the FDA’s Office of Criminal Investigations (OCI), claiming Pfizer knowingly submitted fraudulent data to the FDA, and the agency responded by turning a blind eye.

To grasp the gravity of what is written in the email, it’s important to understand the role of OCI.

What Is OCI?

OCI is the FDA’s criminal law enforcement arm. Much like a police force, it conducts criminal investigations of illegal activities involving FDA-regulated products and brings them before the Department of Justice for prosecution.

OCI consists of about 200 federal agents, hired from the US Secret Service, the FBI, or the Internal Revenue Service Criminal investigations unit. The agents are stationed throughout the US, as well as attachés in overseas posts, and have the same type of arrest authority as other federal law enforcement agents.

The unit was established by former FDA Commissioner David Kessler, off the back of the generic drug scandal in the late 80s. Kessler was determined to crack down on fraud after FDA employees were found guilty of accepting bribes from generic drug makers.

“What I care about most is restoring the credibility and the integrity of the Food and Drug Administration,” said Kessler at the time,” and the only way to do that is to focus on strong enforcement. We are going to enforce the law.”

Since then, many OCI investigations have led to arrests, hefty fines, and imprisonment such as the recent sentencing of two clinical trial researchers in Florida for conspiracy to falsify data by making it appear as though subjects were participating in the trials when, in truth, they were not.

The Leaked Email

The email, dated March 26, 2021, obtained by this reporter details the OCI officer’s observations about the FDA’s handling of Jackson’s complaint.

“Having worked at FDA, I see it as surprising, for many reasons, that the agency turned a blind eye to a company’s knowing submission of fraudulent data,” wrote the OCI officer, whose identity is suppressed after signing a non-disclosure agreement.

The FDA “likely feared the criticism they undoubtedly would have received for holding up a vaccine (which they knew they would eventually approve anyway) at the expense of untold lives lost,” added the OCI officer, acknowledging the FDA’s dilemma in “weighing the risk/benefit ratio.”

According to the email, the FDA had to decide if it served the public better to just approve a vaccine that had much greater efficacy than expected amid the emergency, or make a public issue of Pfizer’s data integrity problems and damage public confidence in the vaccine.

Notably, at the time, AstraZeneca had egg on its face after it released data from an “interim analysis” of its rival adenovirus vector COVID-19 vaccine, claiming 79 percent efficacy.

The trial’s own Data and Safety Monitoring Board called out AstraZeneca for deliberately releasing “outdated and potentially misleading data” and overstating the effectiveness of its vaccine, forcing AstraZeneca to post updated (and less impressive) results.

Reflecting on AstraZeneca’s actions at the time, the OCI officer still thought it was “a far cry” from the company “knowingly submitting false data” but remained concerned that this type of deception would only sow public doubt.

“The general public must be able to trust that the clinical results are valid to sell, approve or take medication,” wrote the OCI officer, quoting a Wall Street Journal article on the AstraZeneca event, adding that it was likely the vaccines were “still extremely likely to be safe and effective.”

“My point here is that instead of the regulators protecting the public, in our case, they were complicit in a fraud. At the time, they may have been doing what they believed to be the right thing under extraordinary circumstances. But now they may soon have some explaining to do,” added the OCI officer, who did not respond to requests for an interview.

Response to Leaked Email?

This reporter reached out to the FDA for comment on claims that it turned a blind eye to fraudulent data, and what, if anything, had been investigated by OCI regarding Jackson’s complaint. The agency said, “The FDA does not comment on possible criminal investigations as a general policy.”

The FDA has consistently underplayed Jackson’s complaint. It has not made a public statement except to say that it had “full confidence in the data that were used to support the Pfizer-BioNTech COVID-19 Vaccine authorization and the Comirnaty approval.”

Those defending the FDA believe that even if there were data integrity issues at the three trial sites at the center of Jackson’s complaint, it would be unlikely to impact Pfizer’s overall trial results.

To be sure, I asked the FDA if it had performed a “sensitivity analysis” to determine if excluding data from the three trial sites would impact the overall trial results, but the agency would not comment.

In response to the leaked email, Pfizer made a statement which is published below in full.

Pfizer’s Nov. 30 Statement

“Pfizer received communication from an anonymous complainant in September 2020 relating to a single clinical investigator site in Texas, USA. We conducted a thorough investigation into the issues raised in accordance with Pfizer’s quality management process related to clinical research. Actions were taken to correct and remediate where necessary. Pfizer’s investigation did not identify any issues or concerns that would invalidate the data or jeopardize the integrity of the study.

The company proactively notified the US Food and Drug Administration of the matter and informed the Institutional Review Board for the study.

The Pfizer-BioNTech BNT162b vaccine was subsequently approved by the FDA, EMA and other regulatory authorities based on the robust data submitted from the clinical program. The vaccine has been given to hundreds of millions of people worldwide following approval. Pfizer has a robust quality management system in place for all aspects of our clinical trials, as they are the foundation of our commitment to patient safety and the integrity of our trials. We take all concerns raised very seriously and thoroughly investigate them, and when necessary taking swift action to address challenges or issues.”

Maryanne Demasi
Maryanne Demasi PhD is an investigative medical reporter with a PhD in rheumatology, who writes for online media and top tiered medical journals. For over a decade, she produced TV documentaries for the Australian Broadcasting Corporation (ABC) and has worked as a speechwriter and political advisor for the South Australian Science Minister. Her work can be accessed on: https://maryannedemasi.substack.com

Blacklisted News Summer Donation Drive

TOP TRENDING ARTICLES


PLEASE DISABLE AD BLOCKER TO VIEW DISQUS COMMENTS

Ad Blocking software disables some of the functionality of our website, including our comments section for some browsers.


Trending Now



BlackListed News 2006-2023
Privacy Policy
Terms of Service